Voyager Therapeutics, Inc. Intellectual Property Contracts & Agreements
7 Contracts & Agreements
- License Agreements (7 contracts)
- First Amendment to Option and License Agreement, by and between Registrant and AstraZeneca Ireland Limited, dated September 30, 2024 (Filed With SEC on November 12, 2024)
- First Amendment to Option and License Agreement, by and between Registrant and Novartis Pharma AG, dated September 3, 2024 (Filed With SEC on November 12, 2024)
- Option and License Agreement by and between the Registrant and Novartis Pharma AG, dated March 4, 2022 (Filed With SEC on March 7, 2023)
- Option and License Agreement by and between the Registrant and Novartis Pharma AG, dated March 4, 2022 (Filed With SEC on May 4, 2022)
- Option and License Agreement, by and between the Registrant and Pfizer Inc., dated October 1, 2021 (Filed With SEC on November 2, 2021)
- First Amendment to Amended and Restated Option and License Agreement with Genzyme Corporation, dated September 20, 2020 (Filed With SEC on November 9, 2020)
- Amended and Restated Option and License Agreement, by and between Voyager Therapeutics, Inc. and Genzyme Corporation, dated June 14, 2019 (Filed With SEC on August 9, 2019)
